Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(27%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
2
18%
Ph not_applicable
3
27%
Ph phase_4
5
45%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
5(45.5%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting3
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 32 (18.2%)
Phase 45 (45.5%)
N/A3 (27.3%)

Trials by Status

unknown218%
recruiting327%
not_yet_recruiting19%
completed545%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11